Drug recall · June 10, 2020
Lamotrigine Tablets recall
Why: Presence of Foreign Substance consistent with granules from desiccant packs used during storage
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.
- Lots / codes
Lot #: a) 25634, b) 25633; Exp. 09/30/2021
- Quantity
- 4124 bottles
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- Nationwide in the U.S.
- Initiated
- May 28, 2020 · Voluntary: Firm initiated
- Classified
- June 4, 2020
- Reported
- June 10, 2020
- Ended
- October 22, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lamotrigine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.